USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Cancer Therapeutics Market Outlook
28-Oct-2005
Global
Market Research
F404-01-00-00-00
HC01452-GL-MR_05946
The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2011.
Introduction
- Introduction
- Disclaimer
- Certification
- Contents
- Top 15 Growth Cancer Therapeutics
Market Overview
- Contents
- Research Scope and Methodology
- Abreviations
- Segmentation
- Targeted Therapy Segments
- Targeted Therapy Definitions
- Summary of Findings
- Market Drivers (1)
- Market Drivers (2)
- Challenges and Strategies (1)
- Challenges and Strategies (2)
- Challenges and Strategies (3)
- Challenges and Strategies (4)
- Challenges and Strategies (5)
Total Market Forecasts
- Contents
- Total Market Forecasts
- Total Market Forecasts by Therapeutic Class
- US Forecasts by Therapeutic Class
- Ex US Forecasts by Therapeutic Class
- Cytotoxic Therapy Forecasts
- Hormone Therapy Forecasts
- Targeted Therapy Forecasts
- Global Market Share Analysis
- US Market Share Analysis
- Ex US Market Share Analysis
NSCLC
- Contents
- Disease Overview
- Epidemiology Trends
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Breast Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Hormone Treatment Diagram
- Metastatic Treatment Diagram
- Revenue Forecasts
- Drug Development
Colorectal Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Prostate Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Top 15 Growth Therapeutic Cancer Drugs (Overview; Indications Development and Forecasts)
- Contents
- Top 15 Growth Therapeutic Cancer Drugs
- Rituxan/MabThera
- Taxotere
- Gleevec/Glivec
- Eloxatin
- Gemzar
- Herceptin
- Zometa
- Casodex
- Arimidex
- Avastin
- Camptosar/Campto
- Temodar/Temodal
- Xeloda
- Femara
- Erbitux
Recent Filings and Approvals
- Contents
- Recent Filings and Approvals
Key Late-Stage Pipeline Drugs
- Contents
- Key Late-Stage Pipeline Drugs
Awards
- Contents
- Frost & Sullivan Awards
- Company of the Year
- Product Innovation of the Year
- Product-Line/Pipeline Strategy of the Year
- Entrepreneurial Company of the Year
- Business Development Strategy of the Year
Frost & Sullivan Capabilities
- Contents
- Our Capabilities I
- Our Capabilities II
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Services Platform
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.